Management of mixed acute rejection driven by a de novo donor-specific complement-binding anti-DQB1*03:01 antibody and intraepithelial CD8 T-cells in a kidney recipient: a case report

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

(2018) M. Haas et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies

(2017) Mark Haas et al.   KIDNEY INTERNATIONAL

Identifying Subphenotypes of Antibody-Mediated Rejection in Kidney Transplants

(2016) P. F. Halloran et al.   AMERICAN JOURNAL OF TRANSPLANTATION

IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury

(2015) C. Lefaucheur et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches

(2014) A. Djamali et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

(2013) Alexandre Loupy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

(2012) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antibody-mediated vascular rejection of kidney allografts: a population-based study

(2012) Carmen Lefaucheur et al.   LANCET